[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Tessem et al., 2007 - Google Patents

A critical role for macrophages in preventing pancreatitis associated diabetes

Tessem et al., 2007

Document ID
3272478960393623922
Author
Tessem J
Pelli H
Dai X
Zong X
Stanley E
Jensen J
Jensen J
DeGregori J
Publication year
Publication venue
Pancreas

External Links

Snippet

Results: Loss of E-cadherin expression clearly correlated with poor survival. None of the tumor samples lacking E-cadherin showed a methylated E-cadherin promotor. PaTu-T cells which also have no E-cadherin expression showed a higher HDAC activity than PaTu-S …
Continue reading at journals.lww.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/574—Immunoassay; Biospecific binding assay for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57419—Specifically defined cancers of colon
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution

Similar Documents

Publication Publication Date Title
Aimoto et al. Controlled release of basic fibroblast growth factor promotes healing of the pancreaticojejunal anastomosis: a novel approach toward zero pancreatic fistula
Lankisch et al. The natural history of acute pancreatitis: a long-term population-based study
Kim et al. Gemcitabine resistance in pancreatic cancer cells is associated with increased expression of stem cell-like markers and a concomitant down-regulation of pten and activation of akt
Hackert et al. Ischemic acute pancreatitis: clinical features, diagnosis, therapy and outcome
Gupta et al. ENDOSCOPIC ULTRASOUND IN MINIMAL CHANGE CHRONIC PANCREATITIS; IS IT AN IDEAL DIAGNOSTIC TOOL?: CORRELATION OF EUS CRITERIA WITH HISTOPATHOLOGY IN PATIENTS UNDERGOING TOTAL PANCREATECTOMY WITH AUTOLOGUS ISLET CELL TRANSPLANTATION
Lomberk et al. HP1 γ has a significant impact on cell cycle progression through the regulation of G2/M, centrosome biology and, chromosomal stability in pancreatic cancer cells
Dudeja et al. Triptolide inhibits heat shock protein 70 (Hsp70) expression by inhibiting dna binding of heat shock factor-1
Lutgendorff et al. Probiotics reduce oxidative stress and pro-inflammatory markers in liver in the early phase of acute pancreatitis
Lankisch et al. TIME TRENDS IN INCIDENCE OF ACUTE PANCREATITIS IN LÜNEBURG: A POPULATION-BASED STUDY
El-Kouhen et al. Control of somatostatin secretion by CCK-1 and CCK-2 receptors in RIN-14B cells, a rat pancreatic islet cell line
Li et al. A novel mechanism for overexpression of TRKB-T1-induced pancreatic cancer metastasis
Kelly et al. Targeted nanoparticles for imaging incipient pancreatic ductal adenocarinoma
Lutgendorff et al. Probiotics maintain mucosal barrier integrity in experimental acute pancreatitis via stabilisation of tight junctions and enhancement of mucosal glutathione
Carlson et al. Pancreatectomy (P) and islet auto-transplantation (IAT) for chronic pancreatitis (CP)
Banerjee et al. In vivo molecular evidence of chemosensitization by 3, 3-diindolylmethane against pancreatic tumor
Osgood et al. DIFFERENTIAL ROLES OF PROTEIN KINASE C ISOFORMS IN ACUTE PANCREATITIS.
Lund et al. An active AKT is required for the hedgehog-mediated survival of pancreatic cancer cells
Adrian et al. TGFβR1 HAPLOINSUFFICIENCY INHIBITS THE DEVELOPMENT OF MURINE MUTANT KRAS-INDUCED PANCREATIC PRECANCER
Crozier et al. Molecular mechanisms of kwashiorkor-induced exocrine pancreas dysfunction
Han et al. Suppressor of fused promotes GLI oncogenic activity in pancreatic cancer
Falkowski et al. Synaptotagmin 1, the neuronal calcium sensing protein for exocytosis and complexin 2 are present in acinar cells and modulate calcium-dependent exocytosis
Tessem et al. A critical role for macrophages in preventing pancreatitis associated diabetes
Gurda et al. Transcriptional profile of calcineurin-NFAT signaling in CCK-induced pancreatic growth
Vallera et al. Genetically designing a more potent anti-pancreatic cancer agent by simultaneously cotargeting human IL-13 and EGF receptors in a mouse xenograft model
Crowell et al. Inhibition of pancreatic adenocarcinoma cell proliferation and invasion by RNAI-mediated knockdown of the PRL-2 tyrosine phosphatase